Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist representation of a digital notepad and pen symbolizing AI in healthcare.

Oct 22, 2026

8 popular AI scribes may need medical device regulation: TGA

The Therapeutic Goods Administration (TGA) has identified that eight out of twelve AI-powered digital scribes may require regulation as medical devices, despite suppliers not classifying them as such.This review, published on October 16, underscores a significant gap in the awareness of medical device regulations among suppliers as AI scribes evolve from simple documentation tools to systems that can influence patient care through recommendations. The TGA has issued guidance to clarify the regul
A minimalist illustration of a pill bottle and a registration number in flat design.

Oct 22, 2026

Seoul St. Mary's automates cancer drug registration

Seoul St. Mary's Hospital has implemented an automated system to enhance the efficiency of patient registration for cancer drug risk management programs, particularly for immunomodulatory drugs used in treating multiple myeloma.The newly developed software, created with the assistance of AI by haematologists at the hospital's Multiple Myeloma Center, simplifies the previous manual process that required over 20 data fields to be filled out for each prescription. Now, clinicians can initiate the r
Press release cover image

Oct 22, 2026

Press release

Merck Collaborates with NVIDIA, Microsoft and Dawn Health to Develop Novel Support Model for People Living with Rare Tumors

Collaboration to explore how AI-facilitated technology can help make patient support programs more individualized, responsive and continuously available to people living with rare tumorsCollaboration brings together clinical and pharmaceutical expertise, digital health product development, and enterprise AI servicesMerck aims to bring the model to patients with desmoid tumors and neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN)DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading s
A molecular model on a petri dish in a dim laboratory setting

Oct 22, 2026

AI-Generated Evidence in Drug Discovery: Reliability, Legal Risk & FDA Compliance

The integration of artificial intelligence (AI) in drug discovery poses significant challenges regarding the reliability of AI-generated evidence, particularly concerning regulatory compliance and legal risks.AI models utilized in drug development are fundamentally probabilistic, which means they can produce outputs that may seem plausible yet be incorrect. This issue is exacerbated by three primary flaws: reliance on incomplete datasets, the opaque nature of AI reasoning, and sensitivity to min
Press release cover image

Oct 21, 2026

Press release

Asimov Announces Adoption of Its AI-Driven Cell Line Development Platform by LG Chem

BOSTON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, today announced a licensing agreement with South Korea-based LG Chem, a leading global chemical company with a diversified business portfolio spanning across petrochemicals, advanced materials, and life sciences. Through this partnership, LG Chem will in-license Asimov’s CHO Edge System to support biologics cell line development activities. “Drug de
Press release cover image

Oct 21, 2026

Press release

Dorsata, Inc. Notifies Patients of Metabase Data Security Incident

CHARLOTTESVILLE, Va., Oct. 21, 2026 /PRNewswire/ -- Dorsata, Inc. has become aware of a data security incident involving the Metabase third-party software it uses that may have involved the protected health information belonging to patients. Dorsata is sending letters to potentially involved individuals to notify them about this incident and provide resources to assist them.On or about August 12, 2026, Dorsata received a notice that the Metabase business intelligence software it uses contained a
A flat illustration of a connector cable representing EHR integration.

Oct 21, 2026

Epic enables EHRs to communicate with other apps

Epic Systems has introduced a new feature called Connectors, designed to enhance the integration of electronic health records (EHRs) with various applications, streamlining interactions for patients, clinicians, and administrative staff.Connectors will facilitate seamless communication between EHRs and multiple applications, including Emmie, an AI agent for patients; Art, an AI tool for clinicians; and Penny, which focuses on revenue cycle management. This functionality aims to reduce the need f
A pipette on a lab bench surrounded by vials and petri dishes in a busy laboratory setting.

Oct 21, 2026

Using AI Agents and Bio-Foundation Models to Automate Vector Design for Cell Line Development

Asimov is leveraging AI and bio-foundation models to enhance vector design, revolutionizing cell line development.In a recent webinar, Jamie Freeman, PhD, Asimov's VP of Business Development and Commercial Strategy, discussed the limitations of traditional drug development processes, which often rely on empirical methods and extensive screening of candidates. He emphasized that as the industry shifts towards more complex formats, such as bispecifics, the conventional trial-and-error approach bec
Minimalist illustration of a pancreas and tumor microenvironment

Oct 21, 2026

Bridging the Translational Gap in Pancreatic Cancer Through Biology-First Modeling

Innovative approaches are reshaping pancreatic cancer research by enhancing the connection between patient biology and preclinical models.Recent advancements in pancreatic cancer therapies highlight the need for improved translational pipelines that effectively link patient biology to preclinical systems. The tumor microenvironment plays a pivotal role in determining patient outcomes and therapeutic responses, necessitating its accurate representation in research models.In an upcoming webinar, J
Press release cover image

Oct 21, 2026

Press release

Limber Health Launches Recovery Forecast, the First-Ever Predicted Outcomes Solution for Rehab Therapy

Built on the largest risk-adjusted patient outcomes database in rehab therapy, Limber's Recovery Forecast replaces traditional single point-in-time forecasts or MCID comparisons with a 90-day outlookPITTSBURGH, Oct. 21, 2026 /PRNewswire/ -- Limber Health, a Net Health company, today announced Recovery Forecast, the first-ever predicted outcomes trajectory solution for rehab therapy. Built into the Limber outcomes platform, Recovery Forecast maps each patient's expected path throughout care by co
Press release cover image

Oct 21, 2026

Press release

Mapmygenome Completes Acquisition of dnaPower Inc. to Accelerate North American Expansion in DNA, Microbiome, Longevity and Precision Health Testing

VANCOUVER, BC, Oct. 21, 2026 /PRNewswire/ -- Mapmygenome announced the completion of its acquisition of Vancouver-based dnaPower Inc., a pioneer in personal genomics. The strategic transaction expands Mapmygenome's North American footprint and establishes a market-leading platform in DNA testing, gut microbiome health, longevity, and AI-driven multi-omics testing.Continue Reading By uniting dnaPower with Mapmygenome's global scale and premier CAP-accredited clinical laboratory c
A glucose sensor on a fermentation vessel in a dimly lit lab setting.

Oct 21, 2026

Raman+NIR Spectra Improves Glucose Soft Sensing

Recent advancements in glucose monitoring techniques could significantly enhance biopharmaceutical manufacturing processes. A new multimodal soft-sensing framework that combines Raman and near-infrared (NIR) spectroscopy has emerged, addressing long-standing challenges in accurate glucose measurement during fed-batch fermentation.This innovative framework enables high-frequency and low-latency glucose measurements, which are often lacking in traditional offline sensors. The approach leverages th